Your search matched 30 results
In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
Virtual delivery requires you to rethink your content and approaches.
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
Demonstrating Value in the Real World | Perspectives
Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
Four Rapid Response Approaches To Maintain Business Momentum
Meet Think Bank | Perspectives
Think Bank is an agile way to answer complex questions.
Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.
Pivot Past the Pandemic | Perspectives
Life sciences commercialization in the COVID-19 era and beyond
Recommendations for activities to inform and engage
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
MM&M eBook: Marketing in a Crisis | In The Media
In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."
At a time when most clinicians are overwhelmed and overworked, Microsoft and GE Healthcare are partnering together to help ease the burden of patient monitoring with a new cloud-based tool.
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
COVID-19: How are Payers Managing These Days? | Perspectives
How are payers responding to COVID-19?
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
Part I of a Syneos Health Series on New Oncology Commercialization Strategies
The response to COVID-19 has brought into sharp focus the need for greater efficiencies in drug discovery and development.